Human Tissue Authority Launches Strategy for 2024-2027
The Human Tissue Authority (HTA) has today published its strategy for 2024-2027, setting out its vision and priorities for regulating the use of human tissue over the next three years.
Key Points:
- The strategy focuses on maintaining public trust and confidence in the safe handling of human tissue, cells and organs.
- Four strategic priorities are outlined: approach to regulation, trust and confidence, use of information, and efficiency and effectiveness.
- The HTA aims to be a more outcome-focused and proportionate regulator, using data and intelligence to target resources.
- There is an emphasis on collaboration with stakeholders and supporting innovation in the life sciences sector.
- The strategy reaffirms core principles of consent, dignity, quality, honesty and openness.
Published on the 20th of August 2024. Read the entire news report here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (5 novembre 2024). Human Tissue Authority Launches Strategy for 2024-2027. ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/12mjd





